Literature DB >> 20092404

Characterization of resistance genes in multidrug-resistant Salmonella enterica serotype Typhimurium isolated from diseased cattle in France (2002 to 2007).

Hayette Targant1, Cécile Ponsin, Christiane Brunet, Benoît Doublet, Axel Cloeckaert, Jean-Yves Madec, Danièle Meunier.   

Abstract

We report here the results of the survey of antimicrobial resistance in 148 serotype Typhimurium strains isolated from cattle in France from 2002 to 2007 and displaying more than two antimicrobial resistances. Salmonella enterica serotype Typhimurium of definitive phage type 104 strains that are commonly resistant to ampicillin-amoxicillin, chloramphenicol-florfenicol, streptomycin-spectinomycin, sulfonamides, and tetracycline (ACSSuT phenotype) harbored resistance genes clustered on a complex class 1 integron In104 of the Salmonella genomic island 1 (SGI1). In our isolates, the most common antimicrobial resistance pattern was ACSSuT (77.7%) or ACSSuT combined to additional resistances. SGI1 was detected in 143 strains and constituted thus the main structure involved in resistance to antimicrobials in these strains. In spite of the high recombination potential of In104, SGI1 variability was quite limited among these strains since only two SGI1 variants, SGI1-B and SGI1-C, were identified. One hundred and thirty-eight out of the 143 SGI1-positive isolates belonged to the DT104 complex. Pulsed-field gel electrophoresis profile A was the most prevalent in 135 SGI1-positive isolates, confirming the diffusion of the DT104 clone. However, changes in phages susceptibility have occurred in three serotype Typhimurium strains of phage type DT12, as they displayed the same pulsed-field gel electrophoresis profile as the SGI1-positive serotype Typhimurium DT104. No variant harboring an additional resistance gene was identified, but the risk of recombination between SGI1 and any other mobile structure carrying other antimicrobial resistance genes is still an issue in serotype Typhimurium.

Entities:  

Mesh:

Year:  2010        PMID: 20092404     DOI: 10.1089/fpd.2009.0414

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.171


  6 in total

1.  From phenotype to genotype: a Bayesian solution.

Authors:  M J Denwood; A E Mather; D T Haydon; L Matthews; D J Mellor; S W J Reid
Journal:  Proc Biol Sci       Date:  2010-10-27       Impact factor: 5.349

2.  Phenotypic-genotypic resistance in Salmonella spp. isolated from cattle carcasses from the north central zone of the State of Mexico.

Authors:  Jorge Antonio Varela-Guerrero; Martin Talavera-Rojas; Adriana del Carmen Gutiérrez-Castillo; Nydia Edith Reyes-Rodríguez; Jesús Vázquez-Guadarrama
Journal:  Trop Anim Health Prod       Date:  2012-12-07       Impact factor: 1.559

3.  Prevalence, distribution, and diversity of Salmonella enterica in a major produce region of California.

Authors:  Lisa Gorski; Craig T Parker; Anita Liang; Michael B Cooley; Michele T Jay-Russell; Andrew G Gordus; E Robert Atwill; Robert E Mandrell
Journal:  Appl Environ Microbiol       Date:  2011-03-04       Impact factor: 4.792

4.  The prevalences of Salmonella Genomic Island 1 variants in human and animal Salmonella Typhimurium DT104 are distinguishable using a Bayesian approach.

Authors:  Alison E Mather; Matthew J Denwood; Daniel T Haydon; Louise Matthews; Dominic J Mellor; John E Coia; Derek J Brown; Stuart W J Reid
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

5.  Diffusion and persistence of multidrug resistant Salmonella Typhimurium strains phage type DT120 in southern Italy.

Authors:  Danila De Vito; Rosa Monno; Federica Nuccio; Marilisa Legretto; Marta Oliva; Maria Franca Coscia; Anna Maria Dionisi; Carla Calia; Carmen Capolongo; Carlo Pazzani
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

6.  "Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?"

Authors:  Claire de Curraize; Lucie Amoureux; Julien Bador; Angélique Chapuis; Eliane Siebor; Claire Clément; Juliette Sauge; Ludwig-Serge Aho-Glélé; Catherine Neuwirth
Journal:  BMC Infect Dis       Date:  2017-12-01       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.